Krittika Goyal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Krittika Goyal has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- David A. Borkholder
Department of Microsystems Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA
1 shared publication - Farzad Forouzandeh
Department of Microsystems Engineering, Rochester Institute of Technology, Rochester, NY 14623, USA
1 shared publication - Joseph P. Walton
University of South Florida
1 shared publication - Nuzhet Nihaar Nasir Ahamed
Microscale Bioseparations Laboratory, Biomedical Engineering Department, Rochester Institute of Technology, 160 Lomb Memorial Drive, Rochester, NY 14623, USA
1 shared publication - Parveen Bazard
Department of Medical Engineering, College of Engineering, University of South Florida, Tampa, FL 33620, USA
1 shared publication - Robert D. Frisina
Department of Medical Engineering University of South Florida Tampa Florida USA
1 shared publication
Latest Publications
- Open Access
- 4 June 2021
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (6) , 538
A Wirelessly Controlled Scalable 3D-Printed Microsystem for Drug Delivery
Here we present a 3D-printed, wirelessly controlled microsystem for drug delivery, comprising a refillable microreservoir and a phase-change peristaltic micropump. The micropump structure was inkjet-printed on the back of a printed circuit board around a catheter microtubing. The enclosure of the microsystem was fabricated using stereolithography 3D printing, with an embedded microreservoir structure and integrated micropump. In one configuration, the microsystem was optimized for murine inner ear drug delivery with an overall size of 19 × 13 × 3 mm3. Benchtop results confirmed the performance of the device for reliable drug delivery. The suitability of the device for long-term subcutaneous implantation was confirmed with favorable results of implantation of a microsystem in a mouse for six months. The drug delivery was evaluated in vivo by implanting four different microsystems in four mice, while the outlet microtubing was implanted into the round window membrane niche for infusion of a known ototoxic compound (sodium salicylate) at 50 nL/min for 20 min. Real-time shifts in distortion product otoacoustic emission thresholds and amplitudes were measured during the infusion, demonstrating similar results with syringe pump infusion. Although demonstrated for one application, this low-cost design and fabrication methodology is scalable for use in larger animals and humans for different clinical applications/delivery sites.
- 4 June 2021
- Published by MDPI AG in Pharmaceuticals
- Vol. 14 (6) , 538
Open AccessA Wirelessly Controlled Scalable 3D-Printed Microsystem for Drug Delivery
Here we present a 3D-printed, wirelessly controlled microsystem for drug delivery, comprising a refillable microreservoir and a phase-change peristaltic micropump. The micropump structure was inkjet-printed on the back of a printed circuit board around a catheter microtubing. The enclosure of the microsystem was fabricated using stereolithography 3D printing, with an embedded microreservoir structure and integrated micropump. In one configuration, the microsystem was optimized for murine inner ear drug delivery with an overall size of 19 × 13 × 3 mm3. Benchtop results confirmed the performance of the device for reliable drug delivery. The suitability of the device for long-term subcutaneous implantation was confirmed with favorable results of implantation of a microsystem in a mouse for six months. The drug delivery was evaluated in vivo by implanting four different microsystems in four mice, while the outlet microtubing was implanted into the round window membrane niche for infusion of a known ototoxic compound (sodium salicylate) at 50 nL/min for 20 min. Real-time shifts in distortion product otoacoustic emission thresholds and amplitudes were measured during the infusion, demonstrating similar results with syringe pump infusion. Although demonstrated for one application, this low-cost design and fabrication methodology is scalable for use in larger animals and humans for different clinical applications/delivery sites.